Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Shares Outstanding: 2023-2025

Historic Shares Outstanding for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to $71.8 billion.

  • Abivax's Shares Outstanding rose 6.01% to $71.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $71.8 billion, marking a year-over-year increase of 6.01%. This contributed to the annual value of $67.7 billion for FY2024, which is 0.02% down from last year.
  • As of Q2 2025, Abivax's Shares Outstanding stood at $71.8 billion, which was up 7.70% from $66.7 billion recorded in Q1 2025.
  • In the past 5 years, Abivax's Shares Outstanding ranged from a high of $71.8 billion in Q2 2025 and a low of $52,594 during Q1 2025.
  • Its 2-year average for Shares Outstanding is $68.8 billion, with a median of $67.7 billion in 2024.
  • Data for Abivax's Shares Outstanding shows a peak YoY increase of 6.01% (in 2025) and a maximum YoY decrease of 99.94% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Abivax's Shares Outstanding stood at $67.7 billion in 2024, then followed by $71.8 billion in 2025.
  • Its last three reported values are $71.8 billion in Q2 2025, $52,594 for Q1 2025, and $67.7 billion during Q4 2024.